{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:43:56Z","timestamp":1767912236525,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO 192\/1"],"award-info":[{"award-number":["KFO 192\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.numecd.2013.04.015","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T03:30:34Z","timestamp":1371612634000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Plasma adiponectin in heart failure with and without cachexia: Catabolic signal linking catabolism, symptomatic status, and prognosis"],"prefix":"10.1016","volume":"24","author":[{"given":"T.","family":"Szab\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Scherbakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sandek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lainscak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.A.","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Rudovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Frystyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Flyvbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.F.H.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2013.04.015_bib1","first-page":"e46","article-title":"Heart disease and stroke statistics\u20132010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2013.04.015_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/euhj.2000.2493","article-title":"The heart failure epidemic: exactly how big is it?","volume":"22","author":"Cleland","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2013.04.015_bib3","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1517\/14656560903117291","article-title":"Overview of emerging pharmacotherapy in chronic heart failure","volume":"10","author":"Szab\u00f3","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.numecd.2013.04.015_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/eurjhf\/hft067","article-title":"Increased catabolic activity in adipose tissue of patients with chronic heart failure","volume":"15","author":"Szabo","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2013.04.015_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ncprheum0674","article-title":"Adipokines as emerging mediators of immune response and inflammation","volume":"3","author":"Lago","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.numecd.2013.04.015_bib6","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2013.04.015_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/cs1030137","article-title":"Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population","volume":"103","author":"Yamamoto","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.numecd.2013.04.015_bib8","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.222657499","article-title":"Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation","volume":"99","author":"Tomas","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2013.04.015_bib9","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","article-title":"Plasma adiponectin levels and risk of myocardial infarction in men","volume":"291","author":"Pischon","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.numecd.2013.04.015_bib10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.5551\/jat.6106","article-title":"Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders","volume":"17","author":"Hirose","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.numecd.2013.04.015_bib11","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.104.530972","article-title":"Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure","volume":"112","author":"Kistorp","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2013.04.015_bib12","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/hrt.2005.083345","article-title":"Circulating adiponectin concentrations in patients with congestive heart failure","volume":"92","author":"George","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.numecd.2013.04.015_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijcard.2008.12.126","article-title":"High plasma adiponectin is related to low functional capacity in patients with chronic heart failure","volume":"144","author":"Laoutaris","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2013.04.015_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2796.2006.01663.x","article-title":"Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure","volume":"260","author":"N\u00f8rrelund","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2013.04.015_bib15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.numecd.2013.04.015_bib16","first-page":"323","article-title":"Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation","volume":"3","author":"Bruce","year":"1971","journal-title":"Ann Clin Res"},{"key":"10.1016\/j.numecd.2013.04.015_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/euhj.1998.1446","article-title":"Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure","volume":"20","author":"Anker","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2013.04.015_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2009.07.030","article-title":"Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure","volume":"147","author":"Szabo","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2013.04.015_bib19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s00125-005-1850-z","article-title":"Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications","volume":"48","author":"Frystyk","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2013.04.015_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1373\/clinchem.2003.021204","article-title":"Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma","volume":"50","author":"Morgenthaler","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2013.04.015_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03345545","article-title":"Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels","volume":"29","author":"Otto","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.numecd.2013.04.015_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCHEARTFAILURE.109.885525","article-title":"Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure","volume":"3","author":"Van Berendoncks","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.numecd.2013.04.015_bib23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1253\/circj.70.1557","article-title":"Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure","volume":"70","author":"Nakamura","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.numecd.2013.04.015_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/CS20090213","article-title":"Exercise training reduces circulating adiponectin levels in patients with chronic heart failure","volume":"118","author":"Van Berendoncks","year":"2010","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.numecd.2013.04.015_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejheart.2008.02.005","article-title":"Effect of atrial natriuretic peptide on adiponectin in patients with heart failure","volume":"10","author":"Tanaka","year":"2008","journal-title":"Eur J Heart Fail"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475313001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475313001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:08:12Z","timestamp":1760544492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475313001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0939475313001178"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2013.04.015","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma adiponectin in heart failure with and without cachexia: Catabolic signal linking catabolism, symptomatic status, and prognosis","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2013.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}